These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


108 related items for PubMed ID: 6145722

  • 1. Abnormal thyrotropin-binding immunoglobulins in two patients with Graves' disease.
    Akamizu T, Ishii H, Mori T, Ishihara T, Ikekubo K, Imura H.
    J Clin Endocrinol Metab; 1984 Aug; 59(2):240-5. PubMed ID: 6145722
    [Abstract] [Full Text] [Related]

  • 2. Anti-bovine TSH antibodies in patients with Graves' disease and primary myxedema.
    Cho BY, Shong YK, Lee HK, Koh CS, Min HK.
    Thyroidology; 1989 Apr; 1(1):31-7. PubMed ID: 2484905
    [Abstract] [Full Text] [Related]

  • 3. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
    Ochi Y, Hamazu M, Kajita Y, Nagata A.
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
    [Abstract] [Full Text] [Related]

  • 4. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
    Kishihara M, Nakao Y, Baba Y, Kobayashi N, Matsukura S, Kuma K, Fujita T.
    J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
    [Abstract] [Full Text] [Related]

  • 5. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 6. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease.
    Noh J, Hamada N, Saito H, Oyanagi H, Ishikawa N, Momotani N, Ito K, Morii H.
    J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548
    [Abstract] [Full Text] [Related]

  • 7. Anti-TSH antibody with high specificity to human TSH in sera from a patient with Graves' disease: its isolation from, and interaction with, TSH receptor antibodies.
    Akamizu T, Mori T, Kasagi K, Kosugi S, Miyamoto M, Nishino K, Sugawa H, Yokota T, Nakamura H, Konishi J.
    Clin Endocrinol (Oxf); 1987 Mar; 26(3):311-20. PubMed ID: 3652477
    [Abstract] [Full Text] [Related]

  • 8. Interference with thyrotropin receptor antibody determination by a spuriously occurring anti-bovine TSH antibody.
    Iitaka M, Tanikawa T, Sakatsume Y, Yanagisawa M, Hara Y, Ishii J.
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):197-203. PubMed ID: 2874680
    [Abstract] [Full Text] [Related]

  • 9. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
    Baker JR, Lukes YG, Smallridge RC, Berger M, Burman KD.
    J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
    [Abstract] [Full Text] [Related]

  • 10. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
    Endo K, Kasagi K, Konishi J, Ikekubo K, Okuno T, Takeda Y, Mori T, Torizuka K.
    J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421
    [Abstract] [Full Text] [Related]

  • 11. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS, Zwicker H, Abbott EC, Douglas R, Givner ML, Gupta MK, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [Abstract] [Full Text] [Related]

  • 12. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
    Tamaki H, Amino N, Watanabe Y, Aozasa M, Hayashi H, Tachi J, Miyai K.
    J Clin Lab Immunol; 1986 May; 20(1):1-6. PubMed ID: 3016274
    [Abstract] [Full Text] [Related]

  • 13. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
    Shinozawa T, Villadolid MC, Ingbar SH.
    J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
    [Abstract] [Full Text] [Related]

  • 14. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P, Harrison LC.
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. IgG thyrotrophin receptor antibody activity in Graves' disease; a study of TSH agonist and antagonist activities by isoelectric focusing.
    Creagh FM, Howells RD, Williams S, Didcote S, Hashim FA, Petersen VB, Rees Smith B.
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):79-88. PubMed ID: 3011318
    [Abstract] [Full Text] [Related]

  • 19. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K.
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of elevated labeled TSH binding (LTB) activity in sera of patients with Graves' disease and other thyroid disorders.
    Akamizu T, Mori T, Ishii H, Yokota T, Nakamura H, Imura H.
    J Endocrinol Invest; 1987 Oct; 10(5):459-64. PubMed ID: 2892876
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.